Similar to the previous study, TP53 and TTN were critical genetic alterations in the pathogenesis of BLCA, and these gene alterations were observed in both the high- and the low-GNG4 groups (Figure S4A). This evidence concerns the gene TTN and bladder transitional cell carcinoma.